TWI738687B - 製備卡前列素氨丁三醇之新穎方法 - Google Patents

製備卡前列素氨丁三醇之新穎方法 Download PDF

Info

Publication number
TWI738687B
TWI738687B TW105139179A TW105139179A TWI738687B TW I738687 B TWI738687 B TW I738687B TW 105139179 A TW105139179 A TW 105139179A TW 105139179 A TW105139179 A TW 105139179A TW I738687 B TWI738687 B TW I738687B
Authority
TW
Taiwan
Prior art keywords
item
patent application
scope
formula
silica gel
Prior art date
Application number
TW105139179A
Other languages
English (en)
Chinese (zh)
Other versions
TW201733980A (zh
Inventor
彼得 布茲德藍托斯
佐茲珊娜 卡多斯
艾朗 阿托巴吉
伊斯塔凡 拉茲佐菲
艾米爾 裘哈斯
拉斯洛 福納吉
薩巴 瓦帝
阿格尼絲 納吉利波科
Original Assignee
匈牙利商齊諾應醫藥及化學品股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 匈牙利商齊諾應醫藥及化學品股份有限公司 filed Critical 匈牙利商齊諾應醫藥及化學品股份有限公司
Publication of TW201733980A publication Critical patent/TW201733980A/zh
Application granted granted Critical
Publication of TWI738687B publication Critical patent/TWI738687B/zh

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/265—Adsorption chromatography
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/42—Selective adsorption, e.g. chromatography characterised by the development mode, e.g. by displacement or by elution
    • B01D15/424—Elution mode
    • B01D15/426—Specific type of solvent
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/02—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material
    • B01J20/10—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material comprising silica or silicate
    • B01J20/103—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material comprising silica or silicate comprising silica
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C7/00—Purification; Separation; Use of additives
    • C07C7/12—Purification; Separation; Use of additives by adsorption, i.e. purification or separation of hydrocarbons with the aid of solids, e.g. with ion-exchangers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Water Supply & Treatment (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TW105139179A 2015-12-01 2016-11-29 製備卡前列素氨丁三醇之新穎方法 TWI738687B (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU1500584A HU231045B1 (hu) 2015-12-01 2015-12-01 Új eljárás Carboprost trometamin elõállítására
HUP1500584 2015-12-01

Publications (2)

Publication Number Publication Date
TW201733980A TW201733980A (zh) 2017-10-01
TWI738687B true TWI738687B (zh) 2021-09-11

Family

ID=89992009

Family Applications (1)

Application Number Title Priority Date Filing Date
TW105139179A TWI738687B (zh) 2015-12-01 2016-11-29 製備卡前列素氨丁三醇之新穎方法

Country Status (10)

Country Link
US (1) US10442762B2 (enExample)
EP (1) EP3383844B8 (enExample)
JP (1) JP6862448B2 (enExample)
KR (1) KR102793118B1 (enExample)
CN (1) CN108602769B (enExample)
ES (1) ES2812770T3 (enExample)
HU (2) HU231045B1 (enExample)
RU (1) RU2729626C2 (enExample)
TW (1) TWI738687B (enExample)
WO (1) WO2017093770A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110117242B (zh) * 2018-02-06 2021-06-22 广州楷模生物科技有限公司 卡前列素、氨丁三醇卡前列素的合成方法
KR102200892B1 (ko) * 2019-05-13 2021-01-12 대원제약주식회사 펠루비프로펜의 신규 염, 이의 제조방법 및 이를 포함하는 약학적 조성물
CN110746333B (zh) * 2019-10-31 2021-06-04 武汉嘉诺康医药技术有限公司 一种分离卡前列素异构体的方法
CN114262288B (zh) * 2020-09-16 2023-07-07 凯特立斯（深圳）科技有限公司 一类前列腺素类化合物合成关键中间体及其制备方法
CN112645861A (zh) * 2020-12-21 2021-04-13 上海彩迩文生化科技有限公司 一种分离卡前列素15位异构体的方法
US12565468B2 (en) 2021-08-23 2026-03-03 Chirogate International Inc. Processes and intermediates for the preparations of Carboprost and Carboprost Tromethamine, and Carboprost Tromethamine prepared therefrom
TWI805504B (zh) * 2021-08-23 2023-06-11 佳和桂科技股份有限公司 卡前列素緩血酸胺之結晶形式及其製備方法
CN113548993B (zh) * 2021-09-01 2022-05-27 河北化工医药职业技术学院 一种卡前列素的制备方法
CN114573489B (zh) * 2022-03-10 2023-08-22 河北化工医药职业技术学院 一种卡前列素的分离方法
CN115010692A (zh) * 2022-05-21 2022-09-06 上海彩迩文生化科技有限公司 一类新颖大环内酯的设计、制备及其应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008081191A1 (en) * 2007-01-05 2008-07-10 Astrazeneca Pharma India Limited Improved method for the wittig reaction in the preparation of carboprost

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3728382A (en) * 1970-05-04 1973-04-17 Upjohn Co 15-methyl and 15-ethyl prostaglandin analogs
IN185790B (enExample) 1997-05-13 2001-04-28 Council Scient Ind Res
WO2011008756A1 (en) 2009-07-13 2011-01-20 Irix Pharmaceuticals Synthesis of prostanoids
CN102336693B (zh) * 2010-07-21 2014-01-22 上海天伟生物制药有限公司 卡前列素氨丁三醇的晶体及其制备方法和用途
CN102816099A (zh) * 2011-06-09 2012-12-12 上海天伟生物制药有限公司 一种高纯度的卡前列素氨丁三醇及其制备方法和用途

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008081191A1 (en) * 2007-01-05 2008-07-10 Astrazeneca Pharma India Limited Improved method for the wittig reaction in the preparation of carboprost

Also Published As

Publication number Publication date
ES2812770T3 (es) 2021-03-18
HU231045B1 (hu) 2020-01-28
RU2729626C2 (ru) 2020-08-11
JP2019502666A (ja) 2019-01-31
KR102793118B1 (ko) 2025-04-07
CN108602769A (zh) 2018-09-28
RU2018123738A3 (enExample) 2020-02-17
TW201733980A (zh) 2017-10-01
KR20180101353A (ko) 2018-09-12
EP3383844B1 (en) 2020-06-03
HUE050782T2 (hu) 2021-01-28
CN108602769B (zh) 2020-11-13
EP3383844A1 (en) 2018-10-10
US10442762B2 (en) 2019-10-15
HUP1500584A2 (en) 2017-06-28
RU2018123738A (ru) 2020-01-09
US20180362457A1 (en) 2018-12-20
WO2017093770A1 (en) 2017-06-08
EP3383844B8 (en) 2020-08-19
JP6862448B2 (ja) 2021-04-21

Similar Documents

Publication Publication Date Title
CN108602769B (zh) 制备卡前列素及其氨丁三醇盐的方法
CN103998423B (zh) 曲伏前列素的制备方法
TWI698431B (zh) 製備具光學活性之貝前列素（Ｂｅｒａｐｒｏｓｔ）之方法
US20030045571A1 (en) Process and intermediates to prepare latanoprost
JP2025160437A (ja) イロプロストの製造のための方法
CN112645861A (zh) 一种分离卡前列素15位异构体的方法
EP2118046A1 (en) Improved method for the wittig reaction in the preparation of carboprost
WO2014094511A1 (zh) 一种制备曲前列尼尔的中间体、其制备方法以及通过其制备曲前列尼尔的方法
HK1254507A1 (en) Process for the preparation of carboprost and its tromethamine salt
HK1254507B (en) Process for the preparation of carboprost and its tromethamine salt
Loza et al. Efficient resolution of some monoprotected derivatives of Corey lactone
WO2013164729A1 (en) An improved and scalable process for preparation of prostaglandin derivatives and intermediates thereof
WO2017093749A1 (en) Process for the preparation of 3-substituted cannabinoid compounds
CN110746450A (zh) 一种贝前列素钠关键中间体的合成方法
KR20200033876A (ko) 미소프로스톨의 제조 및 정제 방법
HK1260257A1 (en) Process for the preparation of optically active beraprost
HK1260257B (en) Process for the preparation of optically active beraprost